BobPitt, It does not deaden my senses, and I ge
Post# of 155581
(Total Views: 505)
Posted On: 04/15/2020 7:32:43 AM
BobPitt,
It does not deaden my senses, and I get lots of information from them.
And I am grateful they are provided.
CYDY could simply "go dark" until the end of the tests and announce one day the results. This is what the majority of companies do. They don't have any obligation to tell us move-by-move the progress of the trials ... Do they ??
What did I learn from today's PR's ?
1) We have 1/5 of patients already enrolled in the mild-to-moderate trial. Gives me information on possible timing for completion.
2) We started the Severe-Critical (meaning the protocol is ready as enrollment means the FDA already approved the trial methodology, not a trivial task).
3) We are working in Oncology simultaneously.
4) 5 more patients have been treated with Leronlimab under EIND in two days meaning doctors are finding it useful to continue treating emergency patients with Leronlimab. This is very important information for me.
I don't know about you, but I include this information (and any other) in my D.D. and decide about my current budget allocation(s) likewise.
GLTU
It does not deaden my senses, and I get lots of information from them.
And I am grateful they are provided.
CYDY could simply "go dark" until the end of the tests and announce one day the results. This is what the majority of companies do. They don't have any obligation to tell us move-by-move the progress of the trials ... Do they ??
What did I learn from today's PR's ?
1) We have 1/5 of patients already enrolled in the mild-to-moderate trial. Gives me information on possible timing for completion.
2) We started the Severe-Critical (meaning the protocol is ready as enrollment means the FDA already approved the trial methodology, not a trivial task).
3) We are working in Oncology simultaneously.
4) 5 more patients have been treated with Leronlimab under EIND in two days meaning doctors are finding it useful to continue treating emergency patients with Leronlimab. This is very important information for me.
I don't know about you, but I include this information (and any other) in my D.D. and decide about my current budget allocation(s) likewise.
GLTU
(7)
(0)